PHOBRIGA (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: PHOBRIGA (Laos)

PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos (commonly known as the Lao "Second Factory"). It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard maintenance starting dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, PHOBRIGA provides the same active ingredient as the originator at a lower cost.

What Is PHOBRIGA Used For?

PHOBRIGA is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients who have progressed on or cannot tolerate crizotinib. It is an oral, once-daily monotherapy that keeps treatment simple and home-based, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does PHOBRIGA (Brigatinib) Work?

The active ingredient brigatinib is a next-generation ALK inhibitor that also targets ROS1, IGF-1R, and FLT-3. It shuts down ALK-driven growth signaling and penetrates the brain, which helps control brain metastases. The generic PHOBRIGA reproduces the same mechanism and active ingredient as the originator at a more accessible price.

Indications

PHOBRIGA is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. The medicine is not suitable for ALK-negative tumors and is not indicated for small-cell lung cancer.

Dosage

The standard schedule is 90 mg once daily for the first 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food at the same time each day and swallow it whole. Do not double up on a missed or vomited dose.

Side Effects

Common side effects include diarrhea, rash, cough, high blood pressure, fatigue, nausea, muscle pain, and headache. Blood pressure should be checked regularly, and diarrhea is usually manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store PHOBRIGA below 30°C in a dry place, inside the original packaging, and away from children. There is no cold-chain requirement.

Why Choose the GLT?

For patients who pay for treatment themselves, a Lao generic such as PHOBRIGA is a far more economical option than the originator brand, whose Western list price can be several times higher. GLT sources from established manufacturers and provides the documentation needed for international delivery, so patients can keep up affordable, uninterrupted therapy.

How to Order

To order PHOBRIGA through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is PHOBRIGA a generic of brigatinib? Yes. PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos.

What strength does PHOBRIGA come in? This listing is the 90 mg strength in a 30-tablet box, which matches the lead-in dose and the standard 90 mg maintenance dose of the brigatinib schedule.

Where can I buy generic brigatinib? Generic brigatinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.

Related Oncology Products

Tixepa(替尔泊肽)20mg/2mL 和 30mg/2mL 多剂量注射笔 | Drug International | GLT

Tixepa——Drug International Limited (DIL) 替尔泊肽多剂量注射笔,两种官方规格(Tixepa-5=20mg/2mL,Tixepa-7.5=30mg/2mL)用于 2 型糖尿病和肥胖。

Barinat(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Natco Pharma Limited | GLT

由 Natco Pharma Limited(印度)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

康曲欣 KangQuXin(阿伐曲泊帕)20mg×10片 | 北京康蒂尼(Gyre)| GLT

康曲欣 KangQuXin — 阿伐曲泊帕,北京康蒂尼药业(Gyre Therapeutics,纳斯达克:GYRE)出品,中国大陆

AVATODX(阿伐曲泊帕)20mg*30片 | 大熊制药(老挝)| GLT

AVATODX——Bigbear Pharmaceutical (Lao) Co., Ltd. 生产的阿伐曲泊帕 20mg,老挝注册号 06L0985/23,30 片瓶装。

Baricent(巴瑞替尼)2mg | 仿制 JAK1/JAK2 抑制剂 | Incepta Pharmaceuticals Ltd. | GLT

由 Incepta Pharmaceuticals Ltd.(孟加拉国)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

欣可平 XinKePing(阿伐曲泊帕)20mg*10片 | 南京恒生制药 | GLT

欣可平——南京恒生制药(济民可信集团)马来酸阿伐曲泊帕片,原料药与制剂一体化生产,中国大陆

Tirzema(替尔泊肽)2.5/5/7.5mg/0.5mL 单剂量注射笔 | Incepta(孟加拉国)| GLT

Tirzema——Incepta Pharmaceuticals 替尔泊肽单剂量注射笔,三种官方规格(2.5/5/7.5mg/0.5mL),用于 2 型糖尿病和体重管理。

Barinib(巴瑞替尼)2mg | 仿制 JAK1/JAK2 抑制剂 | Drug International Limited | GLT

由 Drug International Limited(孟加拉国)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。